Welcome to IJSDR UGC CARE norms ugc approved journal norms IJRTI Research Journal | ISSN : 2455-2631
INTERNATIONAL JOURNAL OF SCIENTIFIC DEVELOPMENT AND RESEARCH International Peer Reviewed & Refereed Journals, Open Access Journal ISSN Approved Journal No: 2455-2631 | Impact factor: 8.15 | ESTD Year: 2016
Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.15 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI)
Incidence of hypoglycemia in non- diabetic Heart failure with reduced Ejection Fraction (HFrEF-<40%) Patients on Sodium/glucose cotransporter-2 (SGLT-2)inhibitors
Authors Name:
Dr. C. Aravind
, Arun Kumar H
Unique Id:
IJSDR2305280
Published In:
Volume 8 Issue 5, May-2023
Abstract:
— In addition, recent results from the EMPEROR Reduced study of empagliflozin bode well that there will finally be an effective treatment for heart failure patients with preserved left ventricular ejection fraction. Aim of the study is to identify the incidence of Hypoglycemia in Non- diabetic Heart failure patients with reduced Ejection Fraction (<40%) for patients on SGLT2 Inhibitors. Methodology-Cross sectional study. Result and conclusion: Incidence of Hypoglycemia in Non- diabetic patient with Heart failure on SGLT-2 Inhibitors was 36%.
"Incidence of hypoglycemia in non- diabetic Heart failure with reduced Ejection Fraction (HFrEF-<40%) Patients on Sodium/glucose cotransporter-2 (SGLT-2)inhibitors ", International Journal of Science & Engineering Development Research (www.ijsdr.org), ISSN:2455-2631, Vol.8, Issue 5, page no.1784 - 1787, May-2023, Available :http://www.ijsdr.org/papers/IJSDR2305280.pdf
Downloads:
000222062
Publication Details:
Published Paper ID: IJSDR2305280
Registration ID:205862
Published In: Volume 8 Issue 5, May-2023
DOI (Digital Object Identifier):
Page No: 1784 - 1787
Publisher: IJSDR | www.ijsdr.org
ISSN Number: 2455-2631
Facebook Twitter Instagram LinkedIn